Drugs / MP29-02
last change Mar 2020 re-read 3 minutes ago

MP29-02

Investigated by
MEDA Pharma GmbH & Co. KG · University Hospital, Ghent · University of Wuerzburg

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02883439 Aug 2016 → Mar 2020 — University Hospital, Ghent Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MP29-02 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02883439 ↗
Route Intranasal “local nasal application” NCT02883439 ↗